2025 · 4th Quarter (Oct 1 - Dec 31)

BLUE SHIELD OF CALIFORNIA

Filed by MEHLMAN CONSULTING, INC..

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 20, 2026
Income: $50,000.00
Expenses: Not reported
Registrant: MEHLMAN CONSULTING, INC.
Client: BLUE SHIELD OF CALIFORNIA
Filing UUID: c9109b66-cdfa-4592-94b9-6c840f8a06f6
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to prescription drug pricing and transparency. Issues related to health IT & interoperability. S.1105 - No UPCODE Act. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Literal federal measure citations: S.1105, H. Con. Res. 14

PHA · Pharmacy

Issues related to prescription drug pricing and transparency. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Literal federal measure citations: H. Con. Res. 14

MMM · Medicare/Medicaid

Issues related to funding changes and program requirements within Medicaid. PL 119-21, An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Literal federal measure citations: H. Con. Res. 14

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.